389 related articles for article (PubMed ID: 26260662)
41. Employment of methyl 2-pyridyl ketone oxime in 3d/4f-metal chemistry: dinuclear nickel(II)/lanthanide(III) species and complexes containing the metals in separate ions.
Polyzou CD; Nikolaou H; Papatriantafyllopoulou C; Psycharis V; Terzis A; Raptopoulou CP; Escuer A; Perlepes SP
Dalton Trans; 2012 Nov; 41(44):13755-64. PubMed ID: 23069731
[TBL] [Abstract][Full Text] [Related]
42. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
[TBL] [Abstract][Full Text] [Related]
43. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
44. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
45. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes.
de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
48. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
[TBL] [Abstract][Full Text] [Related]
49. Lanthanide(III)/pyrimidine-4,6-dicarboxylate/oxalate extended frameworks: a detailed study based on the lanthanide contraction and temperature effects.
Cepeda J; Balda R; Beobide G; Castillo O; Fernández J; Luque A; Pérez-Yáñez S; Román P; Vallejo-Sánchez D
Inorg Chem; 2011 Sep; 50(17):8437-51. PubMed ID: 21800833
[TBL] [Abstract][Full Text] [Related]
50. Ligand Design for N, O- or N, N-Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity.
Pettinari R; Marchetti F; Di Nicola C; Pettinari C; Galindo A; Petrelli R; Cappellacci L; Cuccioloni M; Bonfili L; Eleuteri AM; Guedes da Silva MFC; Pombeiro AJL
Inorg Chem; 2018 Nov; 57(22):14123-14133. PubMed ID: 30362721
[TBL] [Abstract][Full Text] [Related]
51. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation.
Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
53. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency.
Lord RM; Zegke M; Basri AM; Pask CM; McGowan PC
Inorg Chem; 2021 Feb; 60(3):2076-2086. PubMed ID: 33463147
[TBL] [Abstract][Full Text] [Related]
54. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, characterization and preliminary cytotoxicity evaluation of five lanthanide(III)-plumbagin complexes.
Chen ZF; Tan MX; Liu YC; Peng Y; Wang HH; Liu HG; Liang H
J Inorg Biochem; 2011 Mar; 105(3):426-34. PubMed ID: 21421129
[TBL] [Abstract][Full Text] [Related]
56. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, structure, luminescent, and magnetic properties of carbonato-bridged Zn(II)2Ln(III)2 complexes [(μ4-CO3)2{Zn(II)L(n)Ln(III)(NO3)}2] (Ln(III) = Gd(III), Tb(III), Dy(III); L(1) = N,N'-bis(3-methoxy-2-oxybenzylidene)-1,3-propanediaminato, L(2) = N,N'-bis(3-ethoxy-2-oxybenzylidene)-1,3-propanediaminato).
Ehama K; Ohmichi Y; Sakamoto S; Fujinami T; Matsumoto N; Mochida N; Ishida T; Sunatsuki Y; Tsuchimoto M; Re N
Inorg Chem; 2013 Nov; 52(21):12828-41. PubMed ID: 24151881
[TBL] [Abstract][Full Text] [Related]
58. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and Antiproliferative Insights of Lipophilic Ru(II)-Hydroxy Stearic Acid Hybrid Species.
Drius G; Bordoni S; Boga C; Monari M; Fiori J; Esposito E; Zalambani C; Pincigher L; Farruggia G; Calonghi N; Micheletti G
Molecules; 2023 May; 28(10):. PubMed ID: 37241793
[TBL] [Abstract][Full Text] [Related]
60. Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.
Primik MF; Göschl S; Meier SM; Eberherr N; Jakupec MA; Enyedy É; Novitchi G; Arion VB
Inorg Chem; 2013 Sep; 52(17):10137-46. PubMed ID: 23952332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
